Intrinsic Value of S&P & Nasdaq Contact Us

Henry Schein, Inc. HSIC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
51/100
1/7 Pass
SharesGrow Intrinsic Value
$147.54
+91.1%
Analyst Price Target
$90.17
+16.8%

Henry Schein, Inc. (HSIC) reported total assets of $11.22B and total liabilities of $6.42B for quarter ending 2025-12-27, resulting in total equity of $4.79B.

The company held $156M in cash and short-term investments. Total debt stood at $3.69B, with net debt of $3.53B. The Debt-to-Equity (D/E) ratio was 0.77 (moderate).

Current ratio is 1.38, suggesting adequate short-term liquidity. Interest coverage is 4.8x (adequate).

Criteria supported by this page:

  • HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (53/100) — Total assets $11.22B and equity $4.79B support the company's competitive scale
  • VALUE (48/100) — Debt-to-Equity 0.77 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 51/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
51/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
53/100
Proven by this page
GROWTH
30/100
→ Income
INCOME
30/100
→ Income
Henry Schein, Inc. Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $11.22B$11.1B$10.91B$10.48B
Total Liabilities $6.42B$6.2B$6.01B$5.76B
Total Debt $3.69B$3.44B$3.36B$3.22B
Cash & Investments $156M$136M$145M$127M
Total Stockholders Equity $3.25B$3.36B$3.45B$3.31B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message